Carpinteria-based ValenTX, a developer of treatments for obesity, has raised $20.28M in an equity funding round, according to a regulatory filing by the firm Thursday. Details on the funding have not been released by the company. ValenTx has previously raised capital from EDF Ventures, Sapient Capital, Affinity Capital Partners, Kaiser-Permanente Ventures and T-Gap Ventures. More information »